Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest - Lin, Shwu-Bin; Li, Chyi-Hann; Lee, Shiuh-Sheng; Kan, Lou-Sing (Life sciences (1973), 2003)
Keywords: Carcinoma, Hepatocellular - drug therapy; Carcinoma, Hepatocellular - enzymology; Chemical Fractionation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal - chemistry; Drugs, Chinese Herbal - pharmacology; G. lucidum; G2 Phase - drug effects; Liver Neoplasms - drug therapy; Liver Neoplasms - enzymology; MAP kinases; Mitogen-Activated Protein Kinases - biosynthesis; p38 Mitogen-Activated Protein Kinases; PKC; Protein Kinase C - antagonists & inhibitors; Protein Kinase C - metabolism; Reishi - chemistry; Triterpenes; Triterpenes - pharmacology; Tumor Cells, Cultured - drug effects; Tumor Cells, Cultured - enzymology; Tumorcidal; G. lucidum; Triterpenes; PKC; Tumorcidal; MAP kinases